Alogliptin: a novel molecule for improving glycemic control in type II diabetes mellitus.

Current diabetes reviews

Volumn 6, Issue 6, 2010, Pages 410-421

  Ghatak, Somsuvra B ^a   Patel, Devang S ^b   Shanker, Neeraj ^b   Srivstava, Ambrish ^b   Deshpande, Shrikalp S ^b   Panchal, Shital J ^b  

^a NIRMA UNIVERSITY   (India)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALOGLIPTIN; DIPEPTIDYL PEPTIDASE IV INHIBITOR; DRUG DERIVATIVE; GLUCAGON LIKE PEPTIDE 1; INCRETIN; PIPERIDINE DERIVATIVE; URACIL;

ANIMAL; BLOOD; CHEMISTRY; CLINICAL TRIAL (TOPIC); DRUG EFFECT; DRUG INTERACTION; GLUCOSE BLOOD LEVEL; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PHYSIOLOGY; REVIEW; STRUCTURE ACTIVITY RELATION;

ANIMALS; BLOOD GLUCOSE; CLINICAL TRIALS AS TOPIC; DIABETES MELLITUS, TYPE 2; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; DRUG INTERACTIONS; GLUCAGON-LIKE PEPTIDE 1; GLUCAGON-SECRETING CELLS; HUMANS; INCRETINS; INSULIN-SECRETING CELLS; PIPERIDINES; STRUCTURE-ACTIVITY RELATIONSHIP; URACIL;

EID: 79952276785     PISSN: None     EISSN: 18756417     Source Type: Journal    
DOI: None     Document Type: Review

References (0)